Press release
Personalised medicine: milestone in the therapy control of humanised antibodies
CENiMED GmbH, BioTeZ Berlin-Buch GmbH and Invitek Gesellschaft für Biotechnik & Biodesign mbH (company for biotechnology and bio-design) announce their cooperation in the development, production and marketing of Recovery-ELISAs for the therapy control of a new group of therapeutics, the so called humanised antibodies.Humanised antibodies offer unforeseen potentialities in cancer therapy, e. g. for the treatment of mamma carcinoma. Previous therapy control methods, however, could not avoid overdoses which had caused adverse reactions with the patients. Recovery-ELISA (R-ELISA) is an innovative, patented ELISA technique for the determination of the exact efficacy concentration of the therapeutic antibodies and the therapy control. The automation of this technique will be established by a renowned platform manufacturer and then will be made available for the patients and the pharmaceutical industry.
“For the first time possibilities for a patient-specific therapy with humanised antibodies will be available” expresses Dr. Bendzko, CEO of Invtek Gesellschaft für Biotechnik & Biodesign mbH.
Dr. Pavel Strohner, CEO of BioTeZ Berlin-Buch GmbH and developer of this novel R-ELISA test, is a leading expert in the field of ELISA technology. The Berlin location is proud of this epochal development. This is yet another demonstration of the potentials and successes of a cooperation of several innovative biotechnological companies.
“This is yet another important milestone for the implementation of personalised medicine with the patients” complements Dr. Volker Muschalek, CEO of CENiMED GmbH.
About Invitek Biotechnology & Biodesign Ltd.
INVITEK BIOTECHNOLOGY & BIODESIGN LTD. is a worldwide acting provider of innovative, high-quality solutions and technical support to the life sciences and diagnostics industry. Since 1992 the company is internationally acclaimed for its outstanding and high performance technology platform and offers a broad spectrum of superior products for nucleic acid purification, molecular diagnostics, drug discovery and biomedical research. Within the modular product concept “I-tek solution”, Invitek combines its technological developments in complete solutions for molecular diagnostics. An example is the successful introduction of an early warning system for colon carcinoma.
Invitek has been certified under EN ISO 9001 : 2000 and EN ISO 13485 : 2003 and produces under EC Directive 98/79/EEC (IVD-MD).
About CENiMED GmbH
CENiMED GmbH - Centre for Individualised Medicine - was established in 2003 as a spin-off of the Charité Universitätsmedizin Berlin, Germany, with the intention to commercialise the results of medical fundamental research in the field of pharmacogenomics. It is a leading bio-medical company in the area of pharmacogenomic services. The company focuses on the development and marketing of services and products for the pharmaceutical industry. Herewith, CENiMED supports their clients from the early phases of drug development to post marketing studies.
CENiMED is located in the Biotech Park, Berlin-Buch, Germany and possesses state-of-the-art genotyping and gene expression laboratories. Its mission is the development of early diagnostic and prognostic products on the basis of patent specific biomarkers.
About BioTeZ GmbH
Biotez Berlin-Buch GmbH, is a biotechnologically oriented company, was established 10 years ago and is situated on the Biotech campus Berlin-Buch since 1992
BioTeZ focuses on the following areas: Bio-diagnostics and food analytics, scientific services for genetic research and biotechnology and Custom oligonucleotide synthesis.
Additionally, the companies’ experts have special experience and know-how in the conjugation and labelling of bio molecules (with HRP, FITC a. o.), development of monoclonal and polyclonal antibodies, ELISA development, Streptavidin coating (high biotin binding capacity, high chemo- and thermo stability) and immuno-affinity columns and chromatography. Through our skills and know-how we have succeeded in establishing theLD BioScreen - a Low Density Biochip - System as a reasonable alternative to micro plates in research labs.
Invitek Biotechnology & Biodesign Ltd.
Robert-Rössle-Str. 10
13125 Berlin
Germany
T: +49 30 9489 3796
F: +49 30 9489 3795
URL: http://www.invitek.de, http://www.cenimed.com
E-Mail:marketing@invitek.de, christine.engel@cenimed.com
Source: Invitek GmbH, CENiMED GmbH
Authors: Sonja Farhangi, Christine Meerstein-Engel
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Personalised medicine: milestone in the therapy control of humanised antibodies here
News-ID: 24038 • Views: …
More Releases from Invitek Biotechnology & Biodesign Ltd.
Invitek concludes strategic alliance with Chinese partners
In November 2007 a master agreement between Invitek Biotechnology & Biodesign Ltd., Allrun Nano Science & Technology Co., Ltd. and Research Institute of Micro/Nano Science & Technology in Shanghai Jiao Tong University was signed at the 3rd International Nanotechnology Cooperation Symposium in Shanghai, China. Within this agreement the stragetic cooperation for development of new and innovative separation procedures of biomolecules (nucleic acids, proteins) and cells as well as of novel…
Saliva test instead of blood test
New product – SaliGene® Collection Tube
The SaliGene® Collection Tube is the easiest way to collect and preserve large amounts of DNA from saliva. It is easy-to-use and completely non-invasive, making it ideal for reliable self-administered collection. As part of the PSP® Spin Saliva DNA Kit SaliGene® features an all-in-one system for the collection, preservation, transportation and purification of DNA from saliva. Samples do not require special handling or storage because…
New dimension in automation of nucleic acid purification and molecular diagnosti …
Invitek Biotechnolgy & Biodesign Ltd. announces the introduction of a new generation of superparamagnetic nanoparticles for nucleic acid isolation (InviMag® nano). In cooperation with the Chinese company Allrun Nano Science & Technology CO., Ltd. Invitek will adapt and extend its product portfolio for manual and fully automated magnetic extraction of nucleic acids during autumn 2007. The high-performance paramagnetic nanobeads with a controlled surface featuring various functionalities are applicable for efficient…
More Releases for GmbH
The Baby Food Sector in Hungary 2018 | Hipp GmbH & Co Export KG, Milupa GmbH (Da …
The Baby Food Sector in Hungary 2018
"The Baby Food Sector in Hungary, 2018", is an analytical report by Publisher which provides extensive and highly detailed current and future market trends in the Hungarian market.
Hungary's birth rate remains among the lowest in Europe. Demand for baby food has held up well, although much of the growth has come in the last four years, boosted by higher numbers of births and economic…
The Baby Food Market in Germany 2018 | Hipp GmbH & Co Vertrieb KG, Milupa Nutric …
The Baby Food Market in Germany 2018
"The Baby Food Market in Germany, 2018", is an analytical report by Publisher which provides extensive and highly detailed current and future market trends in the German market.
German consumers are exceptionally loyal to their favorite baby food brands, and will frequently go to another shop (often a drugmarket) if their supermarket or hypermarket does not offer the brand they are looking for. This is…
Why Is Baby Food Sector Popular In Austria? Key Players are Hipp GmbH & Co Expor …
"The Baby Food Sector in Austria, 2019", is an analytical report by GlobalData which provides extensive and highly detailed current and future market trends in the Austrian market.
Austria is one of the richest countries in the world in terms of GDP per capita with generally high standard of living. The adoption of healthier eating habits is well established in Austria. Austrian parents traditionally spent time preparing meals in the home…
Polymer Solar Cells Market Heliatek GmbH, BELECTRIC OPV GmbH (OPVIUS GmbH), Sola …
The global polymer solar cells market is anticipated to witness expansion at exponential CAGR over the forecast by 2027, according to a report published by Research Report Insights. The report primarily focuses on driver, restraints, challenges and trends in the market. The report even focuses on in-depth market segmentation to project volume and value estimations over the ten year assessment period.
Long-term Overview
According to a report published by RRI, the polymer…
Global 3D Printing Market to 2025| Stratasys, 3D Systems, Solidscape, EOS GmbH, …
Albany, NY, 3rd January : Recent research and the current scenario as well as future market potential of "3D Printing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025" globally.
Global 3D Printing Market: Overview
3D Printing Market report provides analysis for the period 2015 – 2025, wherein the period from 2017 to 2025 is the forecast and 2016 is the base year. The report covers all…
Global BIPV Modules Market 2018 -Belectric Holding GmbH, Heliatek GmbH, Avanics …
Apex Market Reports, recently published a detailed market research study focused on the “BIPV Modules Market” across the global, regional and country level. The report provides 360° analysis of “BIPV Modules Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of BIPV Modules on…
